1. Home
  2. INTT vs CNTX Comparison

INTT vs CNTX Comparison

Compare INTT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • CNTX
  • Stock Information
  • Founded
  • INTT 1981
  • CNTX 2015
  • Country
  • INTT United States
  • CNTX United States
  • Employees
  • INTT N/A
  • CNTX N/A
  • Industry
  • INTT Semiconductors
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTT Technology
  • CNTX Health Care
  • Exchange
  • INTT Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • INTT 77.3M
  • CNTX 78.0M
  • IPO Year
  • INTT 1997
  • CNTX 2021
  • Fundamental
  • Price
  • INTT $6.85
  • CNTX $0.79
  • Analyst Decision
  • INTT Strong Buy
  • CNTX Strong Buy
  • Analyst Count
  • INTT 2
  • CNTX 5
  • Target Price
  • INTT $12.00
  • CNTX $5.25
  • AVG Volume (30 Days)
  • INTT 28.5K
  • CNTX 145.6K
  • Earning Date
  • INTT 08-06-2025
  • CNTX 08-06-2025
  • Dividend Yield
  • INTT N/A
  • CNTX N/A
  • EPS Growth
  • INTT N/A
  • CNTX N/A
  • EPS
  • INTT N/A
  • CNTX N/A
  • Revenue
  • INTT $121,642,000.00
  • CNTX N/A
  • Revenue This Year
  • INTT N/A
  • CNTX N/A
  • Revenue Next Year
  • INTT $10.07
  • CNTX N/A
  • P/E Ratio
  • INTT N/A
  • CNTX N/A
  • Revenue Growth
  • INTT N/A
  • CNTX N/A
  • 52 Week Low
  • INTT $5.24
  • CNTX $0.49
  • 52 Week High
  • INTT $9.77
  • CNTX $2.70
  • Technical
  • Relative Strength Index (RSI)
  • INTT 43.62
  • CNTX 58.08
  • Support Level
  • INTT $6.98
  • CNTX $0.68
  • Resistance Level
  • INTT $7.40
  • CNTX $0.73
  • Average True Range (ATR)
  • INTT 0.36
  • CNTX 0.05
  • MACD
  • INTT -0.03
  • CNTX -0.00
  • Stochastic Oscillator
  • INTT 5.10
  • CNTX 55.65

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: